COMMUNIQUÉS West-GlobeNewswire
Devenez membre PREMIUM
Accèdez sans limite aux 15 000 actualités du site
et recevez gratuitement chaque semaine,
la Newsletter Santé log avec les actus Santé à ne pas manquer !
Je suis déjà membre PREMIUM
-
AMPS ClaimInsight Sponsors Health Plan Alliance Spring Leadership Forum, Connecting Industry Leaders to Drive Innovation
03/04/2025 - 16:00 -
Introducing Noterro GO: The Ultimate Clinic Management Solution for Mobile Practitioners
03/04/2025 - 16:00 -
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
03/04/2025 - 16:24 -
H.H.C. Group Releases White Paper on High-Cost Healthcare Claims and Cost-Containment Strategies
03/04/2025 - 16:51 -
Odosek Lab Solutions Expands Mobile DNA Testing Services in Columbia, South Carolina
03/04/2025 - 17:16 -
Arialief Vitamins Reviews & Complaints (EXPOSED 2025) Arialief For Neuropathy and Nerve Health
03/04/2025 - 17:20 -
Resolutions from the Annual General Meeting 2025
03/04/2025 - 17:43 -
Déclaration d'actions et de droits de vote de la société Valneva SE - Mars 2025
03/04/2025 - 17:45 -
Valneva SE Shareholding Declaration - March 2025
03/04/2025 - 17:45 -
Sai Life Sciences sets up Peptide Research Center in India
03/04/2025 - 11:58 -
Ligandrol (LGD-4033) SARMs: Ligandrol Benefits, Ligandrol Results & Buy Ligandrol Pills Alternatives Ligan 4033 By CrazyBulk
03/04/2025 - 12:55 -
Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)
03/04/2025 - 13:00 -
Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma Test
03/04/2025 - 13:00 -
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
03/04/2025 - 13:00 -
MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates
03/04/2025 - 13:00 -
Repeat: LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
03/04/2025 - 13:12 -
Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome
03/04/2025 - 13:16 -
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care
03/04/2025 - 13:30 -
Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy
03/04/2025 - 13:30
Pages